The Institute of Neurodegenerative Diseases (IMN) was created on January 1st, 2011. It resulted from the merging of several teams originating mainly from two former CNRS units. It led to the pooling of CNRS, INSERM and University personnel and resources dedicated to mainly studying Movement Disorders and Dementias.

Its establishment is the result of considerable effort, and represents a major step forward in the structuring of the Neuroscience research conducted at this site as part of the “Neurocampus” project.

The IMN includes both preclinical and clinical researchers with a clear goal of:

• developing new therapeutic approaches of neurodegenerative disorders by facilitating the translational research from bench to bedside.
• increasing its scientific visibility and attractiveness in translational (Parkinson, Alzheimer, Obsessive compulsive disorders, Addiction) and fundamental neurosciences (Action planning, Cognition, molecular substrates of synaptic transmission) by building on the potential of its teams and the dynamics set in motion since its creation.

Pathophysiology of neuron-oligodendrocyte interactions
Arne Battefeld

Dopamine and neuronal assemblies
Jérôme Baufreton ; François Georges

Monoamines Parkinson and pain
Abdelhamid Benazzouz ; Pascal Fossat

Purinergic mediated neuroinflammation and brain disorders
Eric Boué-Grabot ; Marc Landry

Physiopathology of proteinopathies
Erwan Bezard

Neuroscience, humanities and society
Cédric Brun

SynTeam
Francesca De Giorgi-Ichas ; François Ichas

Network dynamics underlying function & dysfunction of procedural learning
Arthur Leblois ; Nicolas Mallet

IMN clinics
Wassilios Meissner

Computational neuroscience
Nicolas Rougier

Neurofunctional imagining group
Michel Thiebaut de Schotten ; Emmanuel Mellet

NeuroDTx: Neuromodulation and Digital Therapeutics
Fabien Wagner ; Amélie Aussel

Administration and research management
Eric Wattelet